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Abstract 
Human adipose stem cells (ASCs) has been in the limelight since its discovery as a suitable source 
of mesenchymal stem cells (MSCs) in regenerative medicine. Currently, two major techniques are 
used to isolate ASCs, namely liposuction and tissue biopsy. These two methods are relatively 
risk-free but the question as to which method could give a more efficient output remains unclear. 
Thus, this study was carried out to compare and contrast the output generated in regards to 
growth kinetics, differentiation capabilities in vitro, and gene expression profiling. It was found that 
ASCs from both isolation methods were comparable in terms of growth kinetics and tri-lineage 
differentiation. Furthermore, ASCs from both populations were reported as CD44+, CD73+, 
CD90+, CD166+, CD34-, CD45- and HLA-DR-. However, in regards to gene expression, a group of 
overlapping genes as well as distinct genes were observed. Distinct gene expressions indicated that 
ASCs (liposuction) has endoderm lineage propensity whereas ASCs (biopsy) has a tendency to-
wards mesoderm/ectoderm lineage. This information suggests involvement in different functional 
activity in accordance to isolation method. In conclusion, future studies to better understand these 
gene functions should be carried out in order to contribute in the applicability of each respective 
cells in regenerative therapy. 
Key words: mesenchymal, liposuction, biopsy, TLDA, Ingenuity Pathway Analysis. 
Introduction 
It is a known fact that stem cells (SCs) research 
and its application have revolutionized regenerative 
medicine [1]. Bone marrow (BM) mesenchymal stem 
cells (MSCs) was the first source of stem cells to be 
discovered in adults and it is the most frequently 
studied, making it a golden standard in the field of 
regenerative medicine [2]. These cells have the poten-
tial to form adipogenic, osteogenic, chondrogenic, 
myogenic and neurogenic cells both in vitro and in 
vivo [3]. Despite this, harvesting BM-MSCs from BM by 
aspiration technique is a tedious and painful method. 
Surprisingly, identification of MSCs with similar 
characteristics to BM-MSCs have been found in other 
human tissues [4]. 
Among these, SCs from adipose tissue can be 
considered as one of the potential alternative source 
[5]. This is mainly because of their abundant cell source 
for wider therapeutic applicability. Many studies 
have proven that adipose derived stem cells (ASCs) 
could easily expand under in vitro condition, and is 
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able to differentiate into adipogenic, osteogenic, 
chondrogenic, neurogenic and myogenic cells [6]. 
Moreover, ASCs have the ability to secrete adipokines 
(leptin and adiponectin) which plays a fundamental 
role in metabolism regulation and physiological ho-
meostasis [7].  
Clinical studies that were conducted previously 
have shown the applicability of ASCs in different ar-
eas of study. For example, treatment using ASCs 
showed better recovery in a facial lipoatrophy study 
as the tissue absorbance was faster compared to a 
non-treated control group [8]. In wound healing ther-
apy, ASCs (liposuction) was employed on patients 
with radiation wounds. An improvement in healing 
of tissue wound was observed, and the authors pos-
tulated that the lipoaspirate was rich in native ASCs 
that contributed to the effect [9]. There were also cases 
where allogeneic ASCs (liposuction) were imple-
mented in the treatment of hematologic and immu-
nologic disorders like graft versus-host disease, idio-
pathic thrombocytopenic purpura, or pure red cell 
aplasia [10]. It was reported in all cases that there were 
significant improvements and no adverse effects were 
observed. 
Despite this, studies have revealed that ASCs are 
of heterogeneous population [11] and presents varia-
tions in terms of proliferative capacity, population 
doubling time and morphology [12]. Variation was also 
reported in ASCs isolated from different body regions 
[13]. For example, ASCs from subcutaneous adipose 
tissue region have shown higher proliferation rate 
than those from the omental region [14]. Age and body 
mass index (BMI) also play an important role in cell 
yield and growth of ASCs [15].  
Recently, it was found that the mode of har-
vesting influences the potentiality of ASCs, [16] and for 
now the body of information is focused on the yield 
and little knowledge is available beyond this. We 
have previously reported that gene expression and 
growth factor profile echoes the source of tissue from 
where the stem cells are collected, and it indicates 
heterogeneity of stem cell as biologically relevant [17].  
Hence, we speculate that the mode of harvesting 
might influence gene profiling, which ultimately de-
termines the biological functions of the cells in ex vivo 
microenviroenment. Thus, the present study was 
undertaken to examine gene expression and occur-
rence of unusual shift in gene expression when adi-
pose tissues are harvested using two different meth-
ods. 
Materials and Methods 
Donors 
Human subcutaneous adipose tissue and 
lipoaspirate samples were obtained via biopsy 
(lipectomy) and liposuction aspirates, respectively, 
from the same male subjects (n=5; age range: 35-50 
years). BM-MSC cultures were established from do-
nors (n=5; age range: 18-35 years). Tissues were har-
vested under general anesthesia by an experienced 
surgeon. All donors were non-smokers and free from 
HIV and HBV. Verbal and written informed consent 
were obtained from all patients prior to enrollment in 
the study and all procedures have been approved by 
the Medical Ethics Committee, University of Malaya 
(Medical Ethics Clearance Number DF 
CO1107/0066[L]).  
Isolation and expansion of cells  
BM-MSC cultures were established as previously 
described [18]. Briefly, 60 mL of BM were aspirated 
aseptically from the iliac crest of each patient under 
deep sedation. The BM was diluted (1:1) with 
knockout Dulbecco’s modified Eagle’s medium 
(KO-DMEM; Invitrogen, Carlsbad, CA, USA; 
www.invitrogen.com) and centrifuged at 1800 rpm 
for 10 minutes to remove anticoagulants. The super-
natant was discarded and washed once with culture 
medium. Mononuclear cells (MNCs) were isolated by 
layering onto a lymphoprep density gradient (1:2; 
Axis-Shield PoCAS). The MNCs present in the buffer 
coat were washed again with culture medium. The 
mononuclear fractions that also contained MSCs were 
plated onto culture flasks. 
The subcutaneous adipose tissues were isolated 
as previously described [18]. Briefly, after the weight of 
the adipose tissue was determined, it was extensively 
washed with Dulbecco phosphate-buffered saline 
(DPBS; Invitrogen) containing 200 Units/ ML and 200 
µg/mL of penicillin/streptomycin (Invitrogen) to 
remove contaminants such as blood cells. The tissues 
were then minced carefully for 10 minutes with fine 
scissors until 1-mm3 pieces. The fibrous structures and 
visible blood vessels were removed and the extracel-
lular matrix was enzymatically digested at 37°C for 30 
minutes with 0.5% collagenase Type I (Invitrogen). 
This was followed by inactivation of the collagenase 
activity with an equal volume of KO-DMEM (Invi-
trogen)/10% fetal bovine serum (FBS; Hyclone; 
Thermo Fisher Scientific Inc, Waltham, MA). The di-
gested adipose tissue was centrifuged at 1500 rpm for 
5 minutes to obtain a cell pellet. The pellet was 
re-suspended and filtered through a 100-um mesh 
filter (BD Pharmingen, San Diego CA, USA; 
http://www.bdbiosciences.com) to remove debris. 
The suspending portion containing lipid droplets was 
discarded, and the cell pellet was re-suspended and 
washed twice. Contaminating erythrocytes were 
lysed with red blood lysis buffer (Sigma Aldrich), and 
Int. J. Med. Sci. 2014, Vol. 11 
 
http://www.medsci.org 
393 
the remaining cells were transferred onto plates.  
Lipoaspirates were harvested and cultured fol-
lowing the protocols as described before [19]. In brief, 
ASCs obtained using liposuction were washed exten-
sively with sterile DPBS (Invitrogen) to remove con-
taminating debris and red blood cells. After washing, 
the aspirate samples were treated with 0.075% colla-
genase Type I (Invitrogen) in DPBS (Invitrogen) for 60 
minutes at 37oC with gentle agitation. This was fol-
lowed by inactivation of the collagenase activity with 
an equal volume of DMEM-KO (Invitrogen)/10% 
fetal bovine serum (FBS; Hyclone). Centrifugation 
was carried out at 600 rpm for 10 minutes and the cell 
pellets were re-suspended and washed twice. It was 
then filtrated through a 100-um mesh filter (BD 
Pharmingen) to remove the debris and the remaining 
cells were transferred onto tissue culture plates.  
ASCs obtained using biopsy and liposuction 
were cultured in identical culture condition videlicet; 
in T75 cm2 culture flasks (BD Pharmingen) with cul-
ture medium containing KO-DMEM, 0.5% and 10000 
µg/mL of penicillin/ streptomycin (Invitrogen); 1% 
1X Glutamax (Invitrogen) and 10% FBS (Hyclone) 
with humidified atmosphere of 95% of air and 5% of 
CO2 at 37°C with a cell seeding density of 1000 
cell/cm2. Non-adherent cells were removed 48 h after 
initial plating. The medium was replaced every three 
days until the cells reached 80-90% confluency. A 
summary on the isolation and seeding of ASCs from 
both methods is illustrated in Figure 1. 
Growth Kinetics 
A total of 1000 cell/cm2 of BM-MSCS and ASCs 
obtained from biopsy and liposuction were cultured 
in T-25 flasks (BD Pharmingen, San Diego, CA) to 
determine the proliferation rate. Each passage and 
time point had three replicates. Once the cell reached 
90% confluency, the cells were detached by trypsini-
zation. Next, the total cell number of BM-MSCS and 
ASCs in each passage was counted and assessed for 
viability by means of trypan blue dye exclusion. Cells 
were re-plated for subsequent passages with initial 
seeding of 5000 cell/cm2 in T-25-flasks, and a total of 5 
passages were studied in this experiment. Growth 
kinetics was analyzed by calculating population dou-
bling (PD) time using the formula: TD=tlg2/ 
(lgNH-lgNI), where NI represents the inoculum cell 
number; NH the cell harvest number and t the dura-
tion of the culture (in hours).  
Cell Cycle Analysis 
Cells were seeded at 5000 cells/cm2 on a 35-mm 
tissue culture dish (BD Pharmingen) and cultured 
until 90% confluency. The cells were then detached, 
fixed, and permeabilized in 70% ethanol overnight in 
the dark at 4 °C. After that, the cells were treated with 
RNase A (1 mg/ml final concentration), and stained 
with propidium iodide (PI, Roche, 50 μg/ml final 
concentration). DNA content was analyzed on Guava 
Technologies (Millipore, Billerica, MA) flow cytome-
ter using Cyto- soft, Version 5.2, Guava Technologies 
software. 
 
 
Figure 1. Schematic representation of the isolation methods employed to obtain ASCs (biopsy) and ASCs (liposuction) as previously described. Both ASCs were 
treated with collagenase before filtering via cell strainer and seeded in tissue culture flasks. 
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Senescence associated β-galactosidase 
(SA-β-gal) Assay 
The senescence-associated β-galactosidase 
(SA-β-gal) assay was carried out using senescence 
β-galactosidase staining kit (Cell Signaling Technol-
ogy, Danvers, MA, USA, http://www.cellsignal.com) 
according to the manufacturer's instructions. Cells 
were cultured in a 35-mm plate and allowed to attach 
in growth medium until it reached 80% confluency. 
Cells were then washed twice with DPBS - Ca2+, - 
Mg2+ (Invitrogen), fixed and stained using one mL 
staining solution in citrate buffer (pH 6.0) overnight at 
37°C. The developments of blue coloured cells were 
observed under a phase-contrast microscope using 
20X magnifications. Five random fields were taken 
from each of the three replicate samples of ASCs (lip-
osuction) and ASCs (biopsy) as well as BM-MSCs. The 
SA-β-gal assay was calculated using the following 
formula: 
SA-β-gal= (number of senescence cells / total number 
of cell) X 100% 
FACS analysis  
The immunophenotyping characterization of the 
cells were done using flow cytometry at sub-culture 5. 
After reaching 90% confluency, the cells were tryp-
sinized with 0.05% trypsin (Invitrogen) and 
re-suspended in DPBS (Invitrogen) at a cell density of 
1.5×106 cells/mL. A total of 200 µL of the cell suspen-
sion (1 x 105 cells) was incubated with labeled anti-
bodies in the dark for one hour at 37°C. The following 
antibodies were used: CD90-phycoerythrin (PE), 
CD44-PE, CD73-PE, CD166-PE and CD34-PE, 
CD45-Fluorescein-isothyocyanate (FITC) and 
HLA-DR-FITC. FITC- or PE-labeled isotype-matched 
immunoglobulins were used as negative controls. The 
stained cells were analyzed using Guava Technolo-
gies flow cytometer and the results were analyzed 
using Cytosoft, Version 5.2, Guava Technologies. All 
antibodies were purchased from BD Pharmingen.  
Differentiation  
The cultures were initiated at a density of 1000 
cells/cm2 in six-well plates using growth medium 
until confluency, and then subjected to differentiation 
into adipogenic, osteogenic, and chondrogenic line-
ages. 
In order to induce adipogenic differentiation, 
cells were stimulated with KO-DMEM (Invitrogen), 
10% FBS (Hyclone), 1% Glutamax (Invitrogen), 1 µM 
dexamethasone sodium phosphate (Sigma Aldrich), 
10 µg/ml insulin (Sigma Aldrich), 200 µM indometh-
acin (Sigma Aldrich) and 0.5 mM 
3-isobutyl-1-methylxanthine (Sigma Aldrich) for 21 
days. Medium was changed three times per week. 
Lipid droplets were visualized by staining with Oil 
Red O staining (Sigma Aldrich).  
Osteogenic differentiation was induced via con-
ditioned-media containing KO-DMEM (Invitrogen), 
10% FBS (Hyclone), 1% Glutamax (Invitrogen), 0.1µM 
dexamethasone sodium phosphate (Sigma Aldrich), 
0.2 mM L-ascorbic 2 phosphate (Sigma Aldrich) and 
10 mM β-glycero-2-phosphate (Sigma Aldrich) for the 
next 21 days. The induction media was changed twice 
a week. Von Kossa staining was performed to evalu-
ate calcium accumulation.  
Cells were stimulated into chondrogenic differ-
entiation with KO-DMEM (Invitrogen), 6.25 μg/mL 
insulin (Sigma Aldrich), 6.25μg/mL transferrin (Sig-
ma Aldrich), 6.25 μg/mL selenous acid (Sigma Al-
drich), 5.35 μg/mL linoleic acid (Sigma Aldrich), 1.25 
μg/mL bovine serum albumin (Sigma Aldrich), 1 mM 
Pyruvate (Sigma Aldrich) 37.5 μg/mL Ascorbic acid 
(Sigma Aldrich), 10-7 M dexamethasone (Sigma Al-
drich) for the next 21 days. The induction media was 
changed twice a week. The formation of chondrocytes 
was visualized by Alcian Blue (Sigma Aldrich) stain-
ing.  
Colony Forming Unit (CFU) Assay 
The colony forming unit (CFU) assay was de-
termined by re-plating 100 cells in a 35-mm dish (BD 
Bioscience), followed by 14 days of culturing at 37°C 
with 5% CO2 . Then, the cells were rinsed from growth 
media twice using DPBS -Ca2+, -Mg2+ (Invitrogen) and 
fixed with 100% methanol (Mallindkrodt, Hazelwood, 
USA, http://pharmaceuticals.covidien.com) for 20 
minutes at room temperature, followed by 3% crystal 
violet (Sigma Aldrich) staining. Next, the blue stain 
was rinsed out using tap water for four times until the 
dishes became colourless. The dishes were then in-
verted downwards on a clean cloth, and allowed to 
air-dry for several minutes. Stained colonies with 
sizes larger than 2 mm were counted. The CFU of 
ACSs was then calculated using the formula; 
CFU = (the total number of colonies stained / the ini-
tial number of cells) X 100%. 
Gene profiling 
The expression of a focused panel of pluripotent 
and early lineage stem cell markers were analyzed 
using the Human Taqman Low Density Array 
(TLDA) (Applied Biosystems, USA; 
www.appliedbiosystems.com) which contains a 
well-defined set of validated gene expression mark-
ers. The fluorogenic probes and primers (Applied 
Bioystems) were preloaded in the 384 wells of each 
TLDA card. Total RNA was extracted using Trizol 
(Invitrogen) according to the manufacturer’s instruc-
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tions and was stored at -80 °C. The RNA was sub-
jected to DNase I treatment (Ambion) to eliminate any 
traces of contaminating DNA. A total RNA of 1µg was 
then reverse-transcribed into cDNA by using Super-
script II reverse transcriptase (Invitrogen) after treat-
ment with RNase- OUT ribonuclease inhibitor ac-
cording to the manufacturer’s instructions. cDNAs 
were loaded on to the microfluidic cards for thermal 
cycling on an ABI PRISM 7900HT Sequence Detection 
System (Applied Biosystems). Expression values for 
target genes were normalized to the expression of 18s 
rRNA. Transcriptional analysis was performed for 
ASCs (biopsy and liposuction) and BM-MSCs. For 
data analysis, The ABI PRISM 7900HT sequence de-
tection system software (SDS) were used to calculate 
the levels of target ASC (liposuctions and biopsy) 
gene expression in samples relative to the level of 
expression in the calibrator (BM-MSCs) with compar-
ative CT Method (ΔΔCT). A cutoff cycle threshold (Ct) 
value of 35.0 was arbitrarily assigned for estimation of 
the fold change, such that a Ct value above 35 was 
considered to be undetected. 
Confirmation of Differentiation Assay and 
Array using Reverse Transcriptase 
(RT)-Polymerase Chain Reaction (PCR) and 
Real time PCR (qPCR) 
PCR was performed in 0.2 mL Eppendorf tubes 
(Axygen) with a final volume of 12.5 μL. cDNA am-
plification was performed in a thermocycler using Taq 
polymerase supplied with KCl buffer and 1.5mM 
MgCl2 (Invitrogen) at 94°C for 1 min, 58°C for 30 s 
and 72°C for 1 min. PCR products were resolved on 
1.5% agarose (Invitrogen) gel run in 1x Tris bo-
rate–EDTA buffer. The expression of the genes were 
also quantified in duplicates, using SYBR Green 
Master Mix (Applied Biosystems). PCR reactions were 
run on an ABI 7900HT RT–PCR system (Applied Bi-
osystems) and the SDS v 2.1 software was used to 
analyze the results. Gene expression were analyzed 
via comparative CT Method (ΔΔCT) and were nor-
malized to 18s rRNA. The primer sequences are listed 
in Table 1. 
Ingenuity Pathway Analysis (IPA) 
The ''Core Analysis' function included in IPA 
(Ingenuity® Systems Inc., California, USA; 
http://www.ingenuity.com) [20] was used to interpret 
the data in the context of biological processes, path-
ways and networks. The genes that were selected for 
analysis were of RQ value > 2.0 as compared to 
BM-MSC. After the analysis, generated networks are 
ordered by a significance score. On the other side, 
significance of the biological functions and the ca-
nonical pathways were tested by the right-tailed 
p-value from the Fisher Exact test. Selected networks 
were then converted to form pathways via Path De-
signer to show relationships between genes or pro-
teins. 
Statistical methods 
Data are presented as mean ± standard devia-
tion. The descriptive statistical tests were performed 
using the SPSS software for Windows (version 11.0, 
SPSS Predictive Analytics, Chicago, IL and 
http://www.spss.com). Homogeneity of variance 
and normality were also tested. The data were ana-
lyzed using two-way analysis of variance. Tukey's 
post hoc multiple comparison tests were carried out to 
determine the differences between groups. The sig-
nificance level was set at p=0.05. 
 
Table 1. List of genes with primer sequence and the product size 
Gene name Forward Reverse Base pair 
SOX17 GTACGCTGTAGACCAGACCG CTCGCCCTTCACCTTCATGT 314 
ISL1 AGCCCTAATCCTCTCCCGCT TTGCCGCAACCAACACATAG 512 
AFP AGAACCTGTCACAAGCTGTG GACAGCAAGCTGAGGATGTC 675 
POU5F1 CGACCATCTGCCGCTTTGAG CCCCCTGTCCCCCATTCCTA 572 
OLIG2 GGAAAGATGAGTCGGTGGGG GGAAAGATGAGTCGGTGGGG 311 
T (brachury) CAGAATAGGATTGGGAGTACCCAG CAGAATAGGATTGGGAGTACCCAG 298 
NANOG CCTCCTCCATGGATCTGCTTATTCA TCGGCGCCGGGGAGATACAT 259 
RUNX2 GTCACTGTGCTGAAGAGGCT GTCACTGTGCTGAAGAGGCT 119 
HNF-3 Beta GACAAGTGAGAGAGCAAGTG ACAGTAGTGGAAACCGGAG 234 
LAMA1 AGTTCGAACGCTCTGCTGAA AGTTCGAACGCTCTGCTGAA 297 
RUNX2 CACTGGCGCTGCAACAAGA CATTCCGGAGCTCAGCAGAATAA 127 
OSTEOCALCIN CAGAGGTGCAGCCTTTGTGTC TCACAGTCCGGATTGAGCTCA 150 
PPARγ2 ACAGCAAACCCCTATTCCATGCTGT TCCCAAAGTTGGTGGGCCAGAA 159 
LPL TGGACTGGCTGTCACGGGCT GCCAGCAGCATGGGCTCCAA 167 
AGGRECAN AGGGCGAGTGGAATGATGTT GGTGGCTGTGCCCTTTTTAC 68 
COLLAGEN 2A1 CTGCAAAATAAAATCTCGGTGTTCT GGGCATTTGACTCACACCAGT 101 
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Results 
Basic characterizations of BM-MSCs, ASCs 
(liposuction) and ASCs (biopsy)  
ASCs from both liposuction and biopsy tech-
nique showed a spindle and elongated morphology 
resembling fibroblastic appearance of BM-MSCs (Fig. 
2A). Stromal vascular fraction (SVF) count obtained 
from both methods revealed insignificant difference 
with an average of 171500 for ASCs (biopsy) and 
197400 for ASCs (liposuction) (Fig. 2B). Steady incre-
ments in cell number were seen in BM-MSCs, being 
the highest (a five-fold increase in cell number from 
sub-culture SC-1: 2.6±0.62 to SC-5: 10±1.2; p<0.05), 
followed by ASCs obtained through liposuction (a 
five-fold increase in cell number from SC-1:0.91±0.25 
to SC-5: 4.4±0.72; p<0.05) and ASCs from biopsy (a 
three-fold increment in cell number from SC-1 2.5±0.5 
to SC-5: 7.15±1; p<0.05) (Fig. 2C-2D). Nevertheless, 
there was no significant increment in terms of cell 
number between BM-MSC and ASCs (liposuction). 
However, a significant increment was observed be-
tween BM-MSCs, ASCs (biopsy) and ASCs (liposuc-
tion). Further, average cumulative PD time for 
BM-MSCs was 2.25±0.36, ASCs (liposuction) was 
2.7±0.49 and ASCs (biopsy) was 3.05±0.35.  
 
Figure 2. Basic characterisations of ASCs. (A) Morphological features of BM-MSCs, ASCs (liposuction) and ASCs (biopsy) at 10X magnification, via phase contrast 
microscope; (B) SVF count for both ASCs (n=5); (C) and (D) Cell count and Cumulative Population Doubling (CPD), for ASCs (liposuction) and ASCs (biopsy), against 
BM-MSCs as control (* indicates p-value < 0.05); (E) Senescence assay to evaluate the activity of β-galactosidase in cells of BM-MSCs, ASCs (liposuction), and ASCs 
(biopsy); and (F) Cell cycle analysis describing the DNA content in cells from BM-MSCs, ASCs (liposuction) and ASCs (biopsy). Bar = 100 µm. 
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The senescence assay as shown in Figure 2E de-
scribes the activity of β-galactosidase due to cell age-
ing. BM-MSCs has the lowest activity for the 
β-galactosidase assay at 35 ± 6%, followed by ASCs 
(liposuction) with 42 ± 2% and ASCs (biopsy) with 50 
± 2%. This was further revealed in the cell cycle anal-
ysis whereby as shown in Figure 2F, BM-MSCs were 
actively proliferating (S2 + G2 + M = 12.2 % ± 1.43; 
G1/G0: 89%) followed by ASCs (liposuction) (S2 + G2 
+ M = 7.8 % ± 1.43; G1/G0: 91%) and ASCs (biopsy) 
(S2 + G2 + M = 5 % ± 1.43; G1/G0: 95%). In addition, 
the colony-forming unit assay (Fig. 3A) revealed ASCs 
(biopsy) to be slightly better than that of ASCs (lipo-
suction). Immunophenotyping analysis further de-
scribed surface marker expression level between all 
cell lines as depicted in Fig 3B. All cell lines were 
positive (>85%) for CD44, CD73, CD90, and CD166 
markers but negative (<2%) for CD45 and HLA-DR. 
CD34 marker however has shown a slightly higher 
percentage (~5%) and this could be due to contami-
nation of hematopoietic cells as well as perivascular 
stem cells during the analysis. Subsequently, both 
ASCs from liposuction and biopsy have shown good 
response towards the trillineage differentiation. Lipid 
accumulations were relatively higher in BM-MSCs, 
followed by ASCs (liposuction) and ASCs (biopsy). 
However, in osteogenic differentiation, ASCs (lipo-
suction) presented more calcium deposits, followed 
by BM-MSCs and ASCs (biopsy). A similar pattern 
was also seen in chondrogenesis whereby ASCs (lip-
osuction) were shown to have more proteoglycan 
formation, followed by BM-MSCs and ASCs (biopsy), 
as depicted in Figure 3C.  
 
Figure 3. Immunophenotyping and trillineage differentiation. (A) Colony-forming unit (CFU) of both ASCs (liposuction) and ASCs (biopsy). Pictures represent 
triplicates taken at 4x magnification. (B) Fluorescence-activated cell sorting (FACS) analysis describing presence or absence of cell surface markers in both ASCs, with 
BM-MSCs as control. Cells were tested against human antigens CD34, CD44, CD45, CD73, CD90, CD166, and HLA-DR. 7-Amino-actinomycin D (7-AAD) was used 
to check for cell viability. CD, cluster of differentiations. (C) Mesoderm differential potentiality of ASCs in vitro. Adipogenesis was detected by neutral oil droplet 
formation stained with Oil red O at day 21 in ASCs (liposuction) and ASCs (biopsy). Osteogenesis was confirmed by mineralized matrix deposition stained with von 
Kossa staining at day 21 in ASCs (liposuction) and ASCs (biopsy). Chondrogenesis was detected by the presence of proteoglycans stained with Alcian blue at day 21 
in ASCs (liposuction) and ASCs (biopsy). All experiments were conducted at sub-culture 4. Results represent average of 5 culture replicates. Bar = 100 µm. (D) The 
gene expression profile for mesoderm differentiation capacity using real-time as well as reverse-transcription PCR (* indicates p-value < 0.05). 
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Further validation was carried out by means of 
gene expression study of both reverse-transcription 
and real-time PCR to detect as well as quantify the 
presence of related genes to mesodermal differentia-
tion, namely Runx2, Osteoclacin, PPAR-gamma-2, 
LPL, Aggrecan and Collagen 2A1. In general, ASCs 
(liposuction) had a lower Ct value compared to ASCs 
(biopsy). 
Gene clustering based on expression profile 
In order to visualize the global gene expression 
patterns exhibited by all three-cell lines, a heat map 
analysis was performed independently for the Taq-
man Low Density Array (TLDA). For TLDA array, 
increasing (black) and decreasing (green) gene ex-
pression over time were evident, while a number of 
genes also appeared relatively unchanged compared 
to BM-MSCs. In this array, 18.5% of the molecules (71 
genes) increased in ASCs compared to BM-MSCs, 
while 13% (50 genes) were consistently decreased in 
BM-MSCs. The remaining 68.5% (263 genes) exhibited 
nominal changes roughly equivalent to baseline value 
of BM-MSCs. Among the up-regulated genes, 10.67% 
(41 genes) were common to both ASCs (liposuction) 
and ASCs (biopsy), 6.5% (25 genes) were only present 
in ASCs (liposuction) and only 1.3% (5 genes) were 
unique to ASCs (biopsy). On the contrary, out of 50 
down-regulated genes, 5.7% (22 genes) were common 
to both groups whereas 1.6% (6 genes) and 5.7% (22 
genes) were unique to ASCs (liposuction) and ASCs 
(biopsy), respectively (Fig. 4A-4C).  
 
 
 
Figure 4. Diagram summarizing gene expression patterns of ASCs (liposuction) and ASCs (biopsy). (A) Heat map defining gene expressions via Taqman® Low 
Density Array (TLDA) of both ASCs (liposuction) and ASCs (biopsy) with BM-MSCs as control. The gene expression fold change from both sources with BM-MSCs 
as control is depicted from lowest (in green) to highest (in red). (B) and (C) Venn diagram describing number of up-regulated as well as down-regulated genes with 
BM-MSCs as control.  
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Pathway Analysis 
Network analysis was performed using only the 
genes that were up-regulated in both ASCs from lip-
osuction and biopsy and which exhibited more than 
two-fold expression changes compared to BM-MSCs. 
Using the IPA database, a total of four significant 
biofunctions were seen, namely proliferation of cells 
(p value: 7.31E-13), transcription of RNA (4.97E-8), 
development of digestive system (3.46E-7) and pro-
liferation of liver cells (4.32E-5). Across this network, 
several genes exhibited a pivotal role and connected 
all the networks. This includes genes such as 
CTNNB1, POU5F1, DNMT3B, RUNX2, Nanog, and 
NR6A1 which are related to stemness/pluripotency 
[32]. Besides that, the presence of a few endoderm re-
lated genes such as SOX17, ISL1, and AFP were also 
observed. Similarly, network analysis on up-regulated 
genes from ASCs (biopsy) revealed a total of four 
significant functions namely transcription (7.23E-16), 
proliferation of cells (1.36E-14), morphology of nerv-
ous system (1.39E-11), and development of cardio-
vascular system (1.73E-14). A number of key genes 
significantly related to mesodermal/ectodermal lin-
eage were highlighted during the analyses which in-
cludes OLIG2, FOXA2, MNX1, CDX2, and LAMA1. 
 
 
Figure 5. IPA pathway representation of the molecular relationships among differentially expressed genes and proteins of ASCs (liposuction). The network is 
displayed graphically as nodes (proteins) and edges (the biological relationships between the nodes). Various shapes of the nodes represent the functional class of the 
proteins. Edges are displayed with various labels that describe the nature of the relationship between the nodes. Names of proteins corresponding to the abbre-
viations are as follows: ACTC1, actin, alpha, cardiac muscle 1; ACTIN; AFP, alpha-fetoprotein; CD9, CD9 molecule; COL1A1, collagen, type I, alpha 1; Collagen type 
1; CRABP2, cellular retinoic acid binding protein 2; CTNNB1, catenin (cadherin-associated protein), beta 1, 88kDa; DES, desmin; DNMT3B, DNA (cyto-
sine-5-)-methyltransferase 3 beta; EEF1A1, eukaryotic translation elongation factor 1 alpha 1; F Actin; FGF, fibroblast growth factor; FN1, fibronectin 1; GAPDH, 
glyceraldehyde-3-phosphate dehydrogenase; GFAP, glial fibrillary acidic protein; GRB7, growth factor receptor-bound protein 7; IAPP, islet amyloid polypeptide; 
IFITM1, interferon induced transmembrane protein 1; IFITM2, interferon induced transmembrane protein 2; IL6ST, interleukin 6 signal transducer (gp130, oncostatin 
M receptor); ISL1, ISL LIM homeobox 1; KIT, v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; LAMA1, laminin, alpha 1; LAMB1, laminin, beta 1; 
LAMC1, laminin, gamma 1; Laminin; NANOG, Nanog homeobox; NES, nestin; NR6A1, nuclear receptor subfamily 6, group A, member 1; OLIG2, oligodendrocyte 
lineage transcription factor 2; PGF5, placental growth factor; PODXL, podocalyxin-like; POU5F1, POU class 5 homeobox 1; RAF1, v-raf-1 murine leukemia viral 
oncogene homolog 1; REST, RE1-silencing transcription factor; RUNX2, runt-related transcription factor 2; SEMA3A, sema domain, immunoglobulin domain (Ig), 
short basic domain, secreted, (semaphorin) 3A; SERPINA1, serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1; SFRP2, secreted 
frizzled-related protein 2; SOX17, SRY (sex determining region Y)-box 17; SYCP3, synaptonemal complex protein 3; T, brachyury homolog; TFCP2L1, transcription 
factor CP2-like 1; XIST, X (inactive)-specific transcript (non-protein coding); ZFP42, zinc finger protein 42 homolog. 
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Confirmation of array analysis 
Pluripotent markers such as POU5F1, NANOG 
and RUNX2 were shown to be comparable across all 
the cell lines. The Ct value of POU5F1 (OCT4) was 
5.684±0.32, 5.591±0.362 and 5.358±0.4 for BM-MSCs, 
ASCs (liposuction) and ASCs (biopsy), respectively. 
In addition, the Ct value for NANOG was reported as 
6.84±0.06, 6.793±0.09, and 6.865±0.04, for BM-MSCs, 
ASCs (liposuction) and ASCs (biopsy), respectively. 
The RUNX2 gene on the other hand was shown to 
express Ct value of 7.291±0.16 (BM-MSCs), 7.183±0.12 
(ASCs [liposuction]), and 7.265±0.04 (ASCs [biopsy]). 
Furthermore, the mesoderm marker FOXA2 was re-
ported as 6.721±0.46, 6.383±0.12, and 5.651±0.27 for 
BM-MSCs, ASCs (liposuction) and ASCs (biopsy), 
respectively. Endoderm markers like SOX17, ISL1, 
and AFP have shown similar patterns whereby ASCs 
(liposuction) were highly expressed, followed by 
ASCs (biopsy) and BM-MSCs. For example, expres-
sion of SOX17 for ASCs (liposuction), ASCs (biopsy) 
and BM-MSCs were at 5.483±0.239, 6.7168±0.1448 and 
7.508±0.2711, respectively. Gene ISL1 was in the range 
of 5.783±0.32 for ASCs (liposuction), 6.668±0.13 for 
ASCs (biopsy) and 8.314±0.23 for BM-MSCs. Likewise, 
Ct values for the AFP gene were 5.539±0.53 for 
BM-MSCs, 7.158±0.34 for ASCs (liposuction), and 
8.748±0.41 ASCs (biopsy), respectively. In contrast, 
ectodermal markers such as OLIG2, T, and LAMA1 
were seen to be highly expressed in ASCs (biopsy) 
followed by ASCs (liposuction) and BM-MSCs. Ct 
value for OLIG2 was reported as 5.815±0.42 (ASCs 
[biopsy]), 6.218±0.32 (ASCs [liposuction]) and 
6.684±0.37 (BM-MSCs). Gene T was seen to express Ct 
value of 5.795±0.28 for ASCs (biopsy), 6.873±0.39 for 
ASCs (liposuction) and 6.894±0.35 for BM-MSCs. The 
Ct value for LAMA1 was reported as 5.2519±0.44 
(ASCs [biopsy]), 6.439±0.32 (ASCs [liposuction]), and 
6.816±0.43 (BM-MSCs), respectively. 
 
 
Figure 6. IPA pathway representation of molecular relationships among differentially expressed genes and proteins of ASCs (biopsy). The network is displayed 
graphically as nodes (proteins) and edges (the biological relationships between the nodes). Various shapes of the nodes represent the functional class of the proteins. 
Edges are displayed with various labels that describe the nature of the relationship between the nodes. Names of proteins corresponding to the abbreviations are as 
follows: CD9, CD9 molecule; CDX2, caudal-related homeobox 2; CGB, chorionic gonadotropin, beta polypeptide; COL1A1, collagen, type I, alpha 1; COLLAGEN 
TYPE 1; CRABP2, cellular retinoic acid binding protein 2; DES, desmin; FN1, fibronectin 1; FOXA2, forkhead box A2; GAPDH, glyceraldehyde-3-phosphate de-
hydrogenase; IFITM2, interferon induced transmembrane protein 2; IFITM4, interferon induced transmembrane protein 4; IL6ST, interleukin 6 signal transducer 
(gp130, oncostatin M receptor); ISL1, ISL LIM homeobox 1; LAMA1, laminin, alpha 1; LAMININ; MNX1, motor neuron and pancreas homeobox 1; NANOG, Nanog 
homeobox; NES, nestin; OLIG2, oligodendrocyte lineage transcription factor 2; PAX4, paired box 4; POU5F1, POU class 5 homeobox 1; SFRP2, secreted friz-
zled-related protein 2; SYCP3, synaptonemal complex protein 3; T, brachyury homolog. 
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Figure 7. Expression profile of pluripotent and lineage-specific stem cell markers of MSCs. (A) The Ct value of genes analysed in the study by SYBR green-based 
qRT–PCR for BM-MSCs, ASCs (liposuction) and ASCs (biopsy). The lower a cycle threshold (CT) value, the more copies are present in the specific sample. Values 
are presented after normalization to 18s mRNA levels. (B) Semi-quantitative RT–PCR of selected genes for BM-MSCs, ASCs (liposuction) and ASCs (biopsy). Average 
of three replicates is displayed. 
 
Discussion  
In the present study, we performed side-by-side 
comparison between three groups of stem cells de-
rived from bone marrow; adipose tissue obtained us-
ing liposuction and adipose tissue from biopsy. 
BM-MSCs were observed to proliferate better than 
both groups of ASCs, which was corroborated by a 
battery of experiments (higher cell count, population 
doubling as well as lower senescence assay). Our re-
sults were similar to many established studies [21; 22]. 
In regards to ASCs from liposuction and biopsy, the 
former was better in terms of proliferation rate than 
the latter. Surprisingly, our result contradicts with 
previous research that reported a non-significant dif-
ference in regards to cell count between ASCs from 
liposuction and biopsy [22]. However, this study did 
not include a comprehensive experiment related to 
cell proliferation, making it difficult to compare their 
work with ours. Further, trypan blue may not be a 
sensitive method to evaluate cell proliferation [23]. 
BM-MSCs as well as both ASCs were consistent in 
terms of immunophenotyping analysis and were in 
accordance to many previous studies [12; 24]. In addi-
tion, it is worth to note that only 1% of ASCs ex-
pressed the HLA-DR molecule, suggesting their pro-
spects for allogeneic transplantation [22]. Further, as 
expected, all cell lines were able to differentiate into 
all three mesoderm lineages, given the fact that the 
cells are from mesoderm origin [25]. Nevertheless, 
ASCs (liposuction) was seen to perform relatively 
better than ASCs (biopsy) and it can be inferred that 
the former has a more homogenous population of 
stem cells [26]. 
Pathway analysis revealed that ASCs (liposuc-
tion) expressed a few specific genes related to prolif-
eration/stemness; among these genes are CTNNB1, 
POU5F1 (OCT4), DNMT3B and NANOG. We have 
previously reported the expression of Nanog, Oct4, 
and DNMT3B in ASCs [18]. Surprisingly, we also no-
ticed the expression of CTNNB1. Several studies have 
found that this gene plays a significant role in WNT 
signaling in promoting cell proliferation. It also acts 
together with WNT1 and WNT3A genes to inhibit 
osteogenesis differentiation of MSCs [27]. This might 
also explain the reduced degree of differentiation for 
ASCs (liposuction) towards osteogenesis that we ob-
served in this study. The expression of RUNX2 was 
also significant in this study. Besides regulating os-
teogenesis differentiation and bone formation, it also 
suppresses osteoblast differentiation by affecting cell 
cycle progression in the G1 phase [28]. Hence, we pos-
tulate that RUNX2 plays a bigger role in cell prolifer-
ation.  
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Gene expressions in ASCs (liposuction) were 
focused towards endoderm lineage. This is based on 
the expression of SOX17 and ISL1. SOX17 plays an 
important role in the formation of beta cell lines [29]. 
Besides that, another endoderm gene related to beta 
cell line was noticed, which is ISL1 [29]. It is also indi-
rectly involved in digestive system formation [30]. AFP 
gene, which is the entry point towards liver for-
mation, was also seen [31]. EEF1A gene is however 
involved in enzymatic delivery of aminoacyl tRNAs 
to the ribosome and is expressed highly in internal 
organs. This indicates that ASCs (liposuction) may be 
a better source in endoderm related diseases. Our 
results correlate with previous studies which suggest 
that ASCs might be a better stem cell source than 
BM-MSCs for beta cell line [32; 33]. 
It is not surprising to see ASCs (biopsy) ex-
pressing large number of cells linked to mesoderm 
lineage. Neural fate is regarded as the default path-
way of mouse embryonic stem cells (ESCs) [34]. Fur-
ther, Pal et al [35] reported that human (h) ESCs 
(HUES)-9 follows a neural pathway whereas HUES-7 
is present in mesodermal which spontaneously indi-
cates the existance of default pathways in all cell lines. 
Likewise, our data strongly indicates there is a natural 
default pathway embedded in ASCs (biopsy) and the 
pathway is most likely related to the microenviron-
ment that these cells originated from [36]. Both ASCs 
from liposuction and biopsy expressed primary as 
well as mature neuro-ectoderm markers including 
OLIG2, GFAP, and NESTIN. Uniquely, the expression 
of GFAP is only present in ASCs (liposuction) and 
OLIG2 in ASCs (biopsy). OLIG2 is highly related to 
oligodendrocyte formation which also encodes for an 
essential regulator of ventral neuroectodermal pro-
genitor cell fate [37]. GFAP gene on the other hand 
plays an important role in neurogenesis [38]. This 
shows that these cells may rise to different types of 
neuronal cells although further studies needs to be 
done to prove our hypothesis. 
Our findings have relevance in regenerative 
medicine particularly in the usage of ASCs. We have 
compelling evidence demonstrating that isolating 
method plays a crucial role in deciding the fate of 
stem cells. In this study, two methods of isolation 
were employed on the same donor. We have isolated 
biopsy specimens based on previous study [39; 40] on 
the principles that perforating vessels of the ab-
dominal wall do not need to be cut, consequently 
preserving the arterial, venous, and lymphatic net-
works. The main principle is to maintain the normal 
blood supply to the panniculus, avoiding major com-
plications during and after surgery. In contrast to a 
previous report stating that yield for liposuction 
samples were significantly lower compared to biopsy 
sources, we on the other hand did not find any statis-
tically significant difference for both group of cells. 
Nevertheless, upon culturing we found that the pro-
liferation of ASCs (liposuction) was significantly 
higher compared to ASCs (biopsy). The main reason 
behind this phenomenon remains unanswered. 
However, Buschmann et al, [41] have reported that 
adherent ASC fractions influence floating cells from 
attaching to the plastic surface. It is well known that 
stromal vascular fraction (SVF) contains not only 
ASCs but also vascular endothelial cells (VECs), resi-
dent macrophages, lymphocytes, vascular pericytes 
and fibroblasts [42]. Based on this, we postulate that 
non-stem cells such as fibroblasts attaches more 
quickly, preventing other cells from attaching by se-
creting paracrine factors. Perhaps the amount of these 
cells may be less in ASC (liposuction) as compared to 
(biopsy), which ultimately impacts the proliferation 
rate, differentiation capacity and gene profiling in 
subsequent sub-cultures. 
Sub–cultures are necessary in a clinical set-up 
since large numbers of cells are required for trans-
plantation. It was reported that a 70kg patient would 
need approximately 2 x 106 MSCs/kg body weight for 
transplantation [43]. Furthermore, presence of signifi-
cant differences in terms of molecular phenotype 
between ASCs (liposuction) and ASCs (biopsy) in the 
present study shows that utmost vigilance need to be 
given not only on the choice of cell source for a par-
ticular clinical application, but also in isolating and 
maintaining the cells with good tissue practises. 
Key points 
• We found that the basic characteristics (cell pro-
liferation, differentiation and cell surface antigen 
profile) of ASCs (liposuction) and ASCs (biopsy) 
were comparable. 
• Differentially regulated genes from ASCs (lipo-
suction) that were up-regulated suggest endo-
derm lineage propensity. 
• Differentially regulated genes from ASCs (bi-
opsy) that were up-regulated indicate tendency 
towards mesoderm/ectoderm lineage. 
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